Upregulation of PVT1 promotes NSCLC progression through Yes-associated protein 1 (YAP1) mediated Notch pathway activation, boosting Notch1, NICD and Hes1 levels [81]. Here, YAP1 is linked to non-small cell lung carcinoma.